HemaSphere (Aug 2023)
P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY
- Zhong Zheng,
- Huilai Zhang,
- Keshu Zhou,
- Hui Zhou,
- LI Zhang,
- Caixia LI,
- Min Zhou,
- Wenbin Qian,
- Zhiming LI,
- Qingyuan Zhang,
- Ying Cheng,
- Liu Peng,
- Zhenyu LI,
- Liping Su,
- Fei LI,
- Xiuhua Sun,
- Jingwen Wang,
- Yuhuan Gao,
- Xielan Zhao,
- Kunyan LI,
- Kaiyang Ding,
- Zunmin Zhu,
- Ying Wang,
- Hongmei Jing,
- Xiaohong Xu,
- Xin Wang,
- Zimin Sun,
- Da Gao,
- Wei-LI Zhao
Affiliations
- Zhong Zheng
- 1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Huilai Zhang
- 2 Tianjin Cancer Hospital, Tianjin, China
- Keshu Zhou
- 3 Henan Cancer Hospital, Zhengzhou, China
- Hui Zhou
- 4 Hunan Cancer Hospital, Changsha, China
- LI Zhang
- 5 West China Hospital of Sichuan University, Chengdu, China
- Caixia LI
- 6 The First Affiliated Hospital of Soochow University, Suzhou, China
- Min Zhou
- 7 Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
- Wenbin Qian
- 8 The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
- Zhiming LI
- 9 Sun Yat-Sun University Cancer Center, Guangzhou, China
- Qingyuan Zhang
- 10 Haerbin Medical University Cancer Hospital, Haerbin, China
- Ying Cheng
- 11 Jilin Cancer Hospital, Changchun, China
- Liu Peng
- 12 Fudan University School of Medicine Affiliated Zhongshan Hospital, Shanghai, China
- Zhenyu LI
- 13 Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Liping Su
- 14 Shanxi Cancer Hospital, Taiyuan, China
- Fei LI
- 15 First Affiliated Hospital of Nanchang University, Nanchang, China
- Xiuhua Sun
- 16 The Second Hospital of Dalian Medical University, Dalian, China
- Jingwen Wang
- 17 Beijing Tongren Hospital, Capital Medical University, Beijing, China
- Yuhuan Gao
- 18 The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
- Xielan Zhao
- 19 Xiangya Hospital of Central South University, Changsha, China
- Kunyan LI
- 4 Hunan Cancer Hospital, Changsha, China
- Kaiyang Ding
- 21 The First Affiliated Hospital of USTC, Hefei, China
- Zunmin Zhu
- 22 Henan Provincial People’s Hospital, Zhengzhou, China
- Ying Wang
- 23 Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen, China
- Hongmei Jing
- 24 Peking University Third Hospital, Beijing, China
- Xiaohong Xu
- 25 Nantong Tumor Hospital, Nantong, China
- Xin Wang
- 26 Shandong Provincial Hospital, Jinan, China
- Zimin Sun
- 21 The First Affiliated Hospital of USTC, Hefei, China
- Da Gao
- 27 The Affiliated of Inner Mongolia Medical University, Hohhot, China
- Wei-LI Zhao
- 1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- DOI
- https://doi.org/10.1097/01.HS9.0000971292.12638.60
- Journal volume & issue
-
Vol. 7
p. e1263860
Abstract
No abstracts available.
